Girard Sharp attorneys are investigating securities claims on behalf of Acadia Healthcare (NASDAQ: ACHC) investors who sustained losses greater than $100,000.
If you are an Acadia Healthcare investor with over $100,000 in losses, you may have a legal claim.
For a free consultation, fill out the form below or call us toll-free at (866) 981-4800.
Acadia Healthcare Stock Price Drops Over 16%
On September 27, 2024, Acadia Healthcare announced in a filing with the Securities and Exchange Commission, that the company had “received a voluntary request for information from the United States Attorney’s Office for the Southern District of New York as well as a grand jury subpoena from the United States District Court for the Western District of Missouri (W.D.Mo.) related to its admissions, length of stay and billing practices,” and that it “anticipates receiving similar document requests from the U.S. Securities and Exchange Commission and may receive additional document requests from other governmental agencies.” In response, Acadia’s share price dropped over 16%.
This announcement followed a New York Times investigation which found that some Acadia hospitals were keeping patients longer than medically necessary and against the patients’ wills to continue billing their insurance providers. In some instances, patients also reported suffering abuse from Acadia hospital employees.
Did you suffer $100,000 or more in losses as an Acadia Healthcare investor?
Fill out the form to speak to a Girard Sharp attorney about your rights.
Our Commitment to Excellence
Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We recently obtained a $36.5 million securities settlement against Maxar Technologies, a space imagery company, after its share price collapsed following its acquisition of DigitalGlobe. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.
